Getting the skinny on the latest diet pills


Wall Street is betting that three new experimental diet drugs could be huge commercial hits in a super-sizing America, but how comfortable would doctors be with prescribing the pills?. Clinical studies have shown all three -- Vivus Inc.'s (VVUS 5.61, +0.21, +3.89%) Qnexa, Orexigen Therapeutics' (OREX 4.73, +0.18, +3.96%) Contrave and Arena Pharmaceuticals' (ARNA 6.75, +0.16, +2.35%) lorcaserin-- can be effective in helping obese patients lose at least 5% of their body weight. In some cases, patients were even able to shed over 10%, especially when used in conjunction with a diet and exercise regimen. While 5% may sound unimpressive to your average weight watcher, doctors say that even that relatively small drop can yield substantial health benefits. "In diabetes, losing 5% to 10% of body weight can have a big effect. It can have a significant impact on glucose control," said Dr. Kenneth Snow, senior staff physician at the Joslin Diabetes Center in Boston. And as Americans' waist-lines expand, so does the demand for better weight-loss treatments. See CDC obesity statistics.

Read »

Swai Fish
Omega XL
Black Beans
Dijon Mustard
Pinto Beans
Bento Box

phentermine how weight loss fast
Side Effects of Phentermine

learn spanish app ipad apps for kids swift programming tutorial

Getting the skinny on the latest diet pills